Encaleret Shows Rapid Response in Autosomal Dominant Hypocalcemia Type 1 Nancy A. Melville June 14, 2026

https://www.medscape.com/viewarticle/encaleret-shows-rapid-response-autosomal-dominant-2026a1000jyu?ecd=wnl_edit_tpal_etid8426964&uac=148436CN&impID=8426964 CHICAGO — Encaleret, an investigational oral drug, shows promise against the difficult-to-treat autosomal dominant hypocalcemia type 1 (ADH1), normalizing calcium, parathyroid (PTH), and phosphate levels, results from a randomized trial show.